Fig. 13From: Design, synthesis, in vitro anticancer, molecular docking and SAR studies of new series of pyrrolo[2,3-d]pyrimidine derivativesDNA fragmentation detected in breast cell line (MCF7) treated with 14a, 14b, 16b, and 18b. Means with different superscripts (a, b, c, d, e) between treatments in the same column are significantly different at P < 0.05Back to article page